Data Breach Update
…CEO of CMTA, formed the CMT Research Foundation (CMTRF). Sometime thereafter, CMT Research Foundation began using portions of the database to solicit donations for CMT Research Foundation. The Charcot-Marie-Tooth Association…
Clinical Summit 2023 – Impact Report
…estimated 3 million people worldwide who live with CMT. One of the most frequently heard complaints from the CMT community is their doctor doesn’t know much about CMT and therefore…
Orthotic-Management-CMT-David-Misener
…results from mutation in the KIF1B gene (605995) on chromosome 1p36.2 CMT2B (600882), CMT2B1 (605588), CMT2B2 (605589), CMT2C (606071), CMT2D (601472), CMT2E (607684), CMT2F (606595), CMT2G (608591), CMT2H (607731),…
2020_CMTA_PFC_Staying_Active_transcript
…of our board members, Steve O’Donnell is just an amazing athlete. He has CMTX, and he made this CMT exercise series to share with everyone with CMT to show them…
Foot and Hand Care
…the feet is necessary by those with CMT or by a trusted guardian. Foot Structure Changes and CMT Structural changes in the feet and ankles typically occur with CMT. As…
Toxic Medications List For Patients with Charcot-Marie-Tooth Disease
…Information about General Medications & CMT 2023 Update to the CMTA’s Neurotoxic Medication Advisory The Charcot-Marie-Tooth Association (CMTA) recognizes the CMT community’s desire to have access to information on possible…
CMTA Compass
Welcome to COMPASS – CMTA’s Young Adult Program! Are you a young adult over the age of 19 living with CMT? Welcome to COMPASS – CMTA’s Young Adult Program! COMPASS…
Medication Study
…a condition unrelated to CMT. NeuroMeds : download full text. Weimer and Podwall conducted an extensive literature search and found that 22 of 26 reports of neurotoxicity in CMT patients…
CMTA_2016_Annual_Report
…STAR Strategy to Accelerate Research CMT2A CMT2E Assay Development Drug Screening Pre-Clinical Pre-IND Clinical Phase 1 Clinical Phase2 Laboratory Models CMT4 CMT1B CMT1A CMT1X The CMTA is aggressively fighting to…
CMTA_2014_Annual_Report
…immune processes likely affecting CMTX disease progression. CMT2A is caused by dominant mutations in MFN2. The CMTA’s goal with CMT2A is to create an assay that can measure rescue of…